Preliminary Results from the Multicenter, Randomized Phase III Trial (SCIENCE): Comparing Chemotherapy Plus Sintilimab and Chemoradiotherapy Plus Sintilimab Versus Chemoradiotherapy for Neoadjuvant Treatment in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma.
Journal of Clinical Oncology（2025）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要